Similarly, another study found that the activity of plasma kallikrein is elevated in the sera of epilepsy patients, contributing to cleavage of HK and thus upregulating both circulating and hippocampal levels of bradykinin (Simões et al., 2019). The gene discussed is KNG1; the disease is epilepsy.